| Product Name | Topotecan |
|---|---|
| CAS | 123948-87-8 |
| Formula | C23H23N3O5 |
| MW | 421.45 |
| Appearance | |
| Boiling point | 782.9±60.0 °C | Condition: Press: 760 Torr |
| PKa | 8.92±0.40 | Condition: Most Acidic Temp: 25 °C |
| Product Name | Topotecan |
|---|---|
| CAS | 123948-87-8 |
| Formula | C23H23N3O5 |
| MW | 421.45 |
| Appearance | |
| Boiling point | 782.9±60.0 °C | Condition: Press: 760 Torr |
| PKa | 8.92±0.40 | Condition: Most Acidic Temp: 25 °C |
WKQ-0001265
中文名稱：拓撲替康
中文別稱：托泊替康；N-甲苯胺鹽酸鹽；甲胺苯鹽酸鹽；(S)-10-[(二甲氨基)甲基]-4-乙基-4,9-二羥基-1H-吡喃并[3',4':6,7]中氮茚并[1,2-B]喹啉-3,14(4H,12H)-二酮；拓撲替康-d6；2-氮雜二環[2.1.1]己鹽酸；(1R)-1-(嘧啶-5-基)乙烷-1-胺鹽酸；順-4-氨基四氫吡喃-3-醇鹽酸；拓補替康；帕博西林雜質16鹽酸鹽
英文名稱：Topotecan
英文別名：1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (S)-;(4S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;(19S)-8-[(Dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0[2,11].0[4,9].0[15,20]]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione;(S)-Topotecan;10-Hydroxy-9-[(dimethylamino)methyl]-(20S)-camptothecin;9-(N,N-Dimethylaminomethyl)-10-hydroxycamptothecin;Evotopin;Hycamptamine;Hycamptin;NSC 609699;Nogitecan;Potactasol;SKF 104864;SKF-S 104864;TopoCED;Topophore C;Topotecan;Topotecan lactone;ZINC 1611274;
分子式：C23H23N3O5
分子量：421.45
CAS號：123948-87-8
純度：HPLC≥98%
沸點：782.9±60.0 °C | Condition: Press: 760 Torr
密度：1.49±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度數：8.92±0.40 | Condition: Most Acidic Temp: 25 °C
儲存條件：-20℃，干燥、避光、密封
規格：5mg10mg20mg50mg100mg500mg1g2g等應客戶需求包裝
供應單位：四川省維克奇生物科技有限公司
供應電話：028-81700200/4008005713
四川省維克奇生物科技有限公司生產中藥類標準品和天然植物有效單體，主打中藥對照品/標準品/天然植物有效單體，化學合成，抗生素三大板塊。公司推出丹參系列、龍膽系列、蟲草系列等，敬請關注！ 新批次有現貨，歡迎咨詢。
| Functional daidzein enhances the anticancer effect of topotecan and reverses BCRP-mediated drug resistance in breast cancer | ||
| Source:SCI：PHARMACOLOGICAL RESEARCH | Author:Yachen Li | Notes：影響因子：5.574 |
| Reference description | ||
TPT and DAI, whose structures are shown in Fig. 1, were both purchased from Sichuan Weikeqi Biological Tech (Chengdu, China). Primary antibodies of Bax, Bcl-2, p53, p21, caspase 9, cleaved-caspase 9, ERα, BCRP and GAPDH were all purchased from Protein Tech (Wuhan, China). | ||
| Pifithrin-α enhancing anticancer effect of topotecan on p53-expressing cancer cells | ||
| Source:SCI：EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | Author:Yongming Bao | Notes：影響因子：3.466 |
| Reference description | ||
PFTα (Fig. 1A) (≥98%), Propidium iodide (PI) and Methyl thiazolyl tetrazolium (MTT) were purchased from Sigma-Aldrich (USA). TPT (Fig. 1B) (≥98%) was purchased from Sichuan Weikeqi Biological Tech (Chengdu, China). DNA Topoisomerase I (Topo I), pBR322, Trizol reagent, reverse transcription kit and real-time quantitative kit were purchased from Takara (Dalian, China). Annexin V-EGFP/PI cell apoptosis kit | ||
